HOME  |  CONTACT US  |  SUBSCRIBE  |  SUPPORT WLF

Publication Detail


New Jersey High Court Rejects Generic Preemption Defense When Label Updates “Unreasonably” Delayed
Topic: Federalism
By Linda Pissott Reig, a Shareholder with Buchanan Ingersoll & Rooney PC in the firm’s Newark, NJ office, and Alexandre H. Gapihan, an Associate in the firm’s Washington, DC office.
Legal Opinion Letter, December 2, 2016, 2 pages
Download a PDF of the Publication
Publication Summary:

Generic drug makers’ failure to match changes made to the labels of the branded drugs they copy “at the earliest time possible” deprived those companies of a federal-preemption defense in state product-liability litigation.
  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2017 WLF All Rights Reserved